Amgen "sector outperform," target price reduced

24.03.07 - CIBC World Markets

NEW YORK, March 24 (newratings.com) - In a research note published yesterday, analysts at CIBC World Markets reiterate their "sector outperform" rating on Amgen Inc (AMGN). The target price has been reduced from $87 to $72.